Standard BioTools
LAB
LAB
160 hedge funds and large institutions have $337M invested in Standard BioTools in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 47 increasing their positions, 46 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
2% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 46
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
1.28% less ownership
Funds ownership: 75.16% → 73.88% (-1.3%)
Holders
160
Holding in Top 10
2
Calls
$68K
Puts
$49K
Top Buyers
| 1 | +$4.04M | |
| 2 | +$3.39M | |
| 3 | +$1.2M | |
| 4 |
Goldman Sachs
New York
|
+$771K |
| 5 |
RA
Royce & Associates
New York
|
+$764K |
Top Sellers
| 1 | -$5.38M | |
| 2 | -$3.73M | |
| 3 | -$3.26M | |
| 4 |
TM
Tikvah Management
Charlotte,
North Carolina
|
-$1.8M |
| 5 |
Primecap Management
Pasadena,
California
|
-$412K |
